See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI101.61▲ 2.15%
← GRR page
XStocksXray
Market X-Ray report · 22 October 2026

Globe Residency (GRR)

Karachi Stock Exchange · Pakistan · prices in PKR · close of 22 Oct 2026

Key indicators

Last closePKR 16.83
52-week range16.45 – 24.40
Return, 1 month / 3 months−9.9% / −8.3%
Return, 1 year / 3 years+5.4% / +125.6%
TrendBelow its 200-day average
RSI (14)31
Volatility (1 year)20.2%
Worst drawdown (1 year)-11.8%
Average daily value traded26.02M PKR
Dividend yield23.8%

Market X-Ray price-based

74/ 100 · High confidence · ahead of 91% of stocks on this exchange
Trend67
Momentum63
Stability (higher is calmer)96
Liquidity72
Income66

Fair value limited data

Average of 3 modelsPKR 19.83Model uncertainty High
Versus priceUndervalued+18% to fair value

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

2.627.3612.1016.8421.59Fair value $202022-122023-122024-122025-112026-10

Summary

Globe Residency (GRR) trades on the Karachi Stock Exchange in Pakistan. It last closed at PKR 16.83 on 22 October 2026.

Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 43 of 494 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 5.4% and over the last three months it fell 8.3%. Returns are price returns, dividends not included.

Our limited-data fair value is PKR 19.83 (Undervalued, +17.8% to fair value). It averages 3 models built from the earnings and sales this exchange publishes. Their weights were fitted to a professional consensus-style valuation of Pakistani stocks and checked on stocks left out of the fit, but no analyst forecasts are used, so read it as a rough range.

stocksxray.com · page 1
XStocksXray
Globe Residency (GRR)

The five lenses in numbers each metric is ranked against the other stocks on Karachi Stock Exchange

Lens and metricValueScoreReading
Trend67 · FairMixed trend against its averages.
Above 200-day average-0.9%
From 52-week high-26.8%
Momentum63 · FairTypical recent returns for this exchange.
3-month return-8.3%
6-month return5.5%
12-month return, skipping the last month16.9%
Stability (higher is calmer)96 · StrongCalmer than most: low volatility and shallow drawdowns.
Volatility, 1 year (lower is calmer)20.2%
Worst drawdown, 1 year (smaller is calmer)-11.8%
Liquidity72 · StrongTrades actively.
Average daily value traded26.02M PKR
Zero-volume days0.0%
Income66 · FairDividend is typical for this exchange.
Dividend yield23.8%
Years with dividends4

Strengths

  • Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
  • Liquidity: Trades actively.

Weak spots

No lens is weak against its exchange.

Returns

1 week−0.5%
1 month−9.9%
3 months−8.3%
6 months+5.5%
1 year+5.4%
3 years+125.6%
5 years–

Signals

50-day / 200-day average18.06 / 16.98
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.35

Technical summary

DailyStrongly bearish0 bullish · 4 neutral · 12 bearish
WeeklyNeutral5 bullish · 1 neutral · 6 bearish
MonthlyBullish4 bullish · 1 neutral · 2 bearish

Recent dividends

Ex-dividend dateAmount per share
5 Oct 2026PKR 4.0000
12 Aug 2025PKR 3.5000
19 Sep 2024PKR 1.7500
27 Sep 2023PKR 3.0000
26 Sep 2023PKR 3.0000

Fair value models PSX income statement only (no balance sheet or cash flow): only earnings, sales and dividend models can be built

P/E multiplePKR 20.57
P/S multiplePKR 19.69
P/E on average earningsPKR 19.23

How to read this report

Every number comes from end-of-day prices and dividends and the earnings and sales this exchange publishes. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Karachi Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026